(Q46572332)

23 December 2017

title

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors (English)

1 reference

23 December 2017

1 reference

central sensitization

1 reference

6

Rami Burstein

1 reference

23 December 2017

Moshe Jakubowski

1

1 reference

23 December 2017

Dan Levy

2

1 reference

23 December 2017

Itay Goor-Aryeh

3

1 reference

23 December 2017

Beth Collins

4

1 reference

23 December 2017

Zahid Bajwa

5

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

published in

Headache

1 reference

23 December 2017

volume

45

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

850-861

1 reference

23 December 2017

An association between migraine and cutaneous allodynia.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Common problems in pediatric ambulatory surgery: upper respiratory infection, heart murmur, or sickle-cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

A functional analysis of EP4 receptor-expressing neurons in mediating the action of prostaglandin E2 within specific nuclei of the brain in response to circulating interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Ketorolac as a rapid and effective treatment of migraine headache: evaluations by patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Treatment patterns of isolated benign headache in US emergency departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Inflammatory mediators potentiate pain induced by experimental tissue acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Spinal cord glia: new players in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Glial activation: a driving force for pathological pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Ultrastructural analysis of dynorphin B-immunoreactive cells and terminals in the superficial dorsal horn of the deafferented spinal cord of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

A novel interaction between dynorphin(1-13) and an N-methyl-D-aspartate site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

Dynorphin A increases substance P release from trigeminal primary afferent C-fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.05153.X

10.1111/J.1526-4610.2005.05153.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017